Polyclonal Rabbit anti‑Human TXLNA / Alpha Taxilin Antibody (Cy3, aa328‑531, WB) LS‑C700129
Polyclonal Rabbit anti‑Human TXLNA / Alpha Taxilin Antibody (Cy3, aa328‑531, WB) LS‑C700129
Antibody:
TXLNA / Alpha Taxilin Rabbit anti-Human Polyclonal (aa328-531) (Cy3) Antibody
Overview
Antibody:
TXLNA / Alpha Taxilin Rabbit anti-Human Polyclonal (aa328-531) (Cy3) Antibody
Specifications
Description
Alpha Taxilin antibody LS-C700129 is a Cy3-conjugated rabbit polyclonal antibody to human Alpha Taxilin (TXLNA) (aa328-531). Validated for WB.
Target
Human TXLNA / Alpha Taxilin
Synonyms
TXLNA | IL14 | Interleukin 14 | Alpha-taxilin | Taxilin alpha | RP4-622L5.4 | TXLN
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Cy3.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant TXLNa (Lys328-Glu531)
Specificity
The antibody is a rabbit polyclonal antibody raised against TXLNa.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About TXLNA / Alpha Taxilin
Featured Products
Species:
Human
Applications:
IHC, Western blot, ELISA
Species:
Human, Mouse
Applications:
IHC, Western blot, ELISA
Species:
Human, Chimpanzee, Orangutan, Gibbon, Monkey, Bat, Rabbit
Applications:
Western blot
Reactivity:
Mouse
Range:
0.156-10 ng/ml
Source:
E. coli
Tag:
6His, N-terminus + 6His, C-terminus
Source:
E. coli
Tag:
His-T7
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/19/2024